Iron Therapy in Inflammatory Bowel Disease

Area of Science:

• Gastroenterology
• Hematology

Background:

• Iron deficiency anaemia (IDA) is a frequent complication in inflammatory bowel disease (IBD).
• IDA symptoms like fatigue significantly impair IBD patients' quality of life.
• Effective anaemia management is vital for overall patient well-being.

Purpose of the Study:

• To review the diagnosis and management of IDA in IBD patients.
• To discuss the latest advancements in oral and intravenous iron formulations for IBD.

Main Methods:

• Review of current literature on IDA in IBD.
• Analysis of safety and efficacy data for novel oral and intravenous iron preparations.
• Discussion of treatment guidelines and clinical considerations.

Main Results:

• Oral iron, while accessible, presents challenges like side effects and impact on IBD activity.
• Intravenous iron offers superior efficacy but carries risks of hypersensitivity reactions.
• Newer oral formulations demonstrate improved safety and tolerability profiles.

Conclusions:

• Timely iron replacement is essential upon IDA diagnosis in IBD patients.
• Both oral and intravenous iron have distinct advantages and disadvantages.
• Selection of iron formulation should balance efficacy, safety, and patient-specific factors.